Is Memantine + Acetylcholinesterase Inhibitor Treatment Superior to Either Therapy Alone in Alzheimer's Disease?

Article type: Research Article

Authors: Mattace-Raso, Francesco^{; *}

Affiliations: Section of Geriatric Medicine, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands

Correspondence: [*] Correspondence to: Francesco Mattace-Raso, MD, PhD, Head Section of Geriatric Medicine, Department of Internal Medicine, Room D 438, Erasmus University Medical Center, s-Gravendijkwal 230 3015 CE Rotterdam, The Netherlands. Tel.: +31 10 703 5979; Fax: +31 10 703 4768; E-mail: f.mattaceraso@erasmusmc.nl.

Abstract: Alzheimer's disease is the most common form of dementia in the elderly. Currently, there is no established standard treatment for this disease; therefore, the treatment of Alzheimer's disease will be a major challenge for physicians in the next decade in order to ameliorate quality of life of patients and reduce the costs for the communities.

DOI: 10.3233/JAD-140016

Journal: Journal of Alzheimer's Disease, vol. 41, no. 2, pp. 641-642, 2014